Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-α

Circulation

Volumn 97, Issue 14, 1998, Pages 1375-1381

  Bryant, Debora ^a   Becker, Lisa ^a   Richardson, James ^a   Shelton, John ^a   Franco, Fatima ^a   Peshock, Ronald ^a   Thompson, Marita ^a   Giroir, Brett ^a,b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Cardiomyopathy; Heart failure; Magnetic resonance imaging; Myocarditis

Indexed keywords

CYTOKINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; ELECTROCARDIOGRAM; HEART FAILURE; HEART FUNCTION; HUMAN; INFLAMMATION; MOUSE; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 0032515897     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.14.1375     Document Type: Article

References (69)

1. Pennica D, Nedwin GE, Hayflick JS, Seeburg PH, Derynck R, Palladino MA, Kohr WJ, Aggarwal BB, Goeddel DV. Human tumor necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature. 1984;312:724-729.
2. Tracey KJ, Beutler B, Lowry SF. Shock and tissue injury induced by recombinant human cachectin. Science. 1986;234:470-474.
3. Beutler B, Krochin N, Milsark IW, Luedke C, Cerami A. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science. 1986;232:977-980.
4. Oliff A, Defoe-Jones D, Boyer M, Martinez D, Kiefer D, Vuocolo G, Wolfe A, Socher SH. Tumors secreting human TNF/cachectin induce cachexia in mice. Cell. 1987;50:555-563.
5. Tracey KJ, Cerami A. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med. 1994;45:491-503.
6. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol. 1996;14:397-440.
7. Probert L, Akassoglou K, Pasparakis M, Kontogergos G, Kollias G. Spontaneous inflammatory demyelinating disease in transgenic mice snowing central nervous system-specific expression of tumor necrosis factor-alpha. Proc Natl Acad Sci U S A. 1995;92:11294-11298.
8. Michie HR, Manogue KR, Spriggs DR. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med. 1988;318:1481-1486.
9. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990;323:236-241.
10. Mann DL, Young JB. Basic mechanisms in congestive heart failure: recognizing the role of proinflammatory cytokines. Chest. 1994;105:897-904.
11. McMurray J, Abdullah I, Dargie HJ, Shapiro D. Increased concentrations of tumour necrosis factor in 'cachectic' patients with severe chronic heart failure. Br Heart J. 1991;66:356-358.
12. Matsumori A, Yamada T, Suzuki H, Matoba Y, Sasayama S. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J. 1994;72:561-566.
13. Habib FM, Springall DR, Davies GJ, Oakley CM, Yacoub MH, Polak JM. Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet. 1996;347:1151-1155.
14. Kapadia S, Lee J, Torre-Amione G, Birdsall HH, Ma TS, Mann DL. Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest. 1995;96:1042-1052.
15. Giroir BP, Johnson JH, Brown T, Allen GA, Beutler B. The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. J Clin Invest. 1992;90:693-698.
16. Giroir BP, Horton JW, White DJ, McIntyre KL, Lin CQ. Inhibition of tumor necrosis factor (TNF) prevents myocardial dysfunction during burn shock. Am J Physiol. 1994;267:H118-H124.
17. Torre-Amione G, Kapadia S, Lee J, Bies RD, Lebovitz R, Mann DL. Expression and functional significance of tumor necrosis factor receptors in human myocardium. Circulation. 1995;92:1487-1493.
18. Torre-Amione G, Kapadia S, Lee J, Durand J-B, Bies RD, Young JB, Mann DL. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation. 1996;93:704-711.
19. Kapadia SR, Oral H, Lee J, Nakano M, Taffet GE, Mann DL. Hemodynamic regulation of tumor necrosis factor-α and protein expression in adult feline myocardium. Circ Res. 1997;81:187-195.
20. Heard SO, Perkins MW, Fink MP. Tumor necrosis factor-alpha causes myocardial depression in guinea pigs. Crit Care Med. 1992;20:523-527.
21. Pagani FD, Baker LS, Hsi C, Knox M, Fink MP, Visner MS. Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs. J Clin Invest. 1992;90:389-398.
22. Eichenholz PW, Eichacker PQ, Hoffman WD, Banks SM, Parrillo JE, Danner RL, Natanson C. Tumor necrosis factor challenges in canines: patterns of cardiovascular dysfunction. Am J Physiol. 1992;263:H668-H675.
23. Eichacker PQ, Hoffman WD, Farese A, Banks SM, Kuo GC, MacVittie TJ, Natanson C. TNF but not IL-1 in dogs causes lethal lung injury and multiple organ dysfunction similar to human sepsis. J Appl Physiol. 1991;71:1979-1989.
24. Hegewisch S, Weh HJ, Hossfeld DK. TNF-induced cardiomyopathy. Lancet. 1990;2:294-295.
25. Yokoyama T, Nakano M, Bednarczyk JL, McIntyre BW, Entman M, Mann DL. Tumor necrosis factor-alpha provokes a hypertrophic growth response in adult cardiac myocytes. Circulation. 1997;95:1247-1252.
26. Krown KA, Page MT, Nguyen C, Zechner D, Gutierrez V, Comstock KL, Glembotski CC, Quintana PJE, Sabbadini RA. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes: involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest. 1996;98:2854-2865.
27. Kumar A, Thota V, Dee L, Olson J, Uretz E, Parrillo JE. Tumor necrosis factor α and interleukin 1β are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med. 1996;183:949-958.
28. Murray DR, Freeman GL. Tumor necrosis factor-α induces a biphasic effect on myocardial contractility in conscious dogs. Circ Res. 1996;78:154-160.
29. DeMeules JE, Pigula FA, Mueller M, Raymond SJ, Gamelli RL. Tumor necrosis factor and cardiac function. J Trauma. 1992;32:686-692.
30. Muller-Werdan U, Reithman C, Werdan K. Cytokines and the Heart: Molecular Mechanisms of Septic Cardiomyopathy. Austin, Tex: R.G. Landes; 1996.
31. Gulick J, Subramaniam A, Neumann J, Robbins J. Isolation and characterization of the mouse cardiac myosin heavy chain genes. J Biol Chem. 1991;266:9180-9185.
32. Robbins J, Gulick J, Sanchez A, Howles P, Doetschman T. Mouse embryonic stem cells express the cardiac myosin heavy chain genes during development in vitro. J Biol Chem. 1990;265:11905-11909.
33. Williams G, Becker L, Bryant D, Willis S, Giroir BP. Effects of transforming growth factor on nitric oxide synthesis by C2C12 skeletal myocytes. Am J Physiol. 1996;270(1 Pt 2):R145-R152.
34. Benigni F, Sacco S, Pennica D, Ghezzi P. Cardiotrophin-1 inhibits tumor necrosis factor production in the heart and serum of lipopolysaccharide-treated mice and in vitro in mouse blood cells. Am J Pathol. 1996;149:1847-1850.
35. Parrillo JE, Shelhamer JH, Parker MM, Natanson C, Schuette W. A circulating myocardial depressant substance in humans with septic shock: septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J Clin Invest. 1985;76:1539-1553.
36. Reilly JM, Cunnion RE, Burch-Whitman C, Parker MM, Shelhamer JH, Parrillo JE. A circulating myocardial depressant substance is associated with cardiac dysfunction and peripheral hypoperfusion (lactic acidemia) in patients with septic shock. Chest. 1989;95:1072-1080.
37. Suffredini AF, Frinnm RE, Parker MM, Brenner M, Kovacs JA, Wesley RA, Parrillo JE. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med. 1989;321:280-287.
38. Natanson C, Eichenhob PW, Danner RL, Eichacker PQ, Hoffman WD, Kuo GC, Banks SM, MacVittie TJ, Parrillo JE. Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J Exp Med. 1989;169:823-832.
39. Solis RT, Downing SE. Effects of E. coli endotoxemia on ventricular performance. Am J Physiol. 1966;211:307-313.
40. Adams HR, Baxter CR, Parker JL, Watts NB. Contractile function and rhythmicity of cardiac preparation from Escherichia coil endotoxin-shocked guinea pigs. Circ Shock. 1984;13:241-253.
41. Parker JL, Adams HR. Contractile dysfunction of atrial myocardium from endotoxin-shocked guinea pigs. Am J Physiol. 1981;240:H954-H962.
42. Adams HR, Baxter CR, Parker JL. Reduction of intrinsic contractile reserves of the left ventricle by Esherichia coli endotoxin shock in guinea pigs. J Mol Cell Cardiol. 1985;17:575-585.
43. Rubin LJ, Keller RS, Parker JL, Adams HR. Contractile dysfunction of ventricular myocytes isolated from endotoxemic guinea pigs. Shock. 1994;2:113-120.
44. Noshima S, Noda H, Herndon DN, Traber LD, Traber DL. Left ventricular performance during continuous endotoxin-induced hyperdynamic endotoxemia in sheep. J Appl Physiol. 1993;74:1528-1533.
45. Hung J, Lew WYW. Cellular mechanisms of endotoxin-induced myocardial depression in rabbits. Circ Res. 1993;73:125-134.
46. Decking UKM, Flesche CW, Godecke A, Schrader J. Endotoxin-induced contractile dysfunction in guinea pig hearts is not mediated by nitric oxide. Am J Physiol. 1995;268:H2460-H2465.
47. Natanson C, Danner RL, Elin RJ, Hosseini JM, Pean KW, Banks SM, MacVittie TJ, Walker RI, Parrillo JE. Role of endotoxemia in cardiovascular dysfunction and mortality: Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shuck. J Clin Invest. 1989;83:243-251.
48. Natanson C, Danner RL, Fink MP, MacVittie TJ, Walker RI, Conklin JJ, Parrillo JE. Cardiovascular performance with E. coli challenges in a canine model of human sepsis. Am J Physiol. 1988;254:H558-H569.
49. Natanson C, Fink MP, Ballantyne HK, MacVittie TJ, Conklin JJ, Parrillo JE. Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock. J Clin Invest. 1986;78:259-270.
50. Arteaga G, White J, Horton J, Giroir B. Prevention of endotoxin-induced myocardial dysfunction with TNF blockade or IL-1 blockade. Crit Care Med. 1996;24:A144. Abstract.
51. Herbertson MJ, Werner HA, Goddard CM, Russell JA, Wheeler A, Coxon R, Walley KR. Anti-tumor necrosis factor-alpha prevents decreased ventricular contractility in endotoxemic pigs. Am J Respir Crit Care Med. 1995;152:480-488.
52. Lanore JJ, Dhainaut JF, Fisher CJ, Opal SM, Zimmerman J, Nightingale P, Stephens S, Schein RL, Panacek EA, Vincent JL, Foulke GE, Warren EL, Garrard C, Park G, Bodmer MW, Cohen J, van der Linden G, Sadoff JC, Pochard F, CB0006 Study Group. Effects of an anti-TNF IgG monoclonal antibody on left ventricular performance in septic patients. Intens Care Med. 1992;18:S49. Abstract.
53. Boekstegers P, Weidenhofer S, Zell R, Pilz G, Holler E, Ertel W, Kapsner T, Redl H, Schlag G, Kaul M, Kempeni J, Stenzel R, Werdan K, Repeated administration of a F(ab')2 fragment of an anti-tumor necrosis factor alpha-monoclonal antibody in patients with severe sepsis: effects on the cardiovascular system and cytokine levels. Shock. 1994;1:237-245.
54. Katz SD, Rao R, Berman JW, Schwarz M, Demopoulos L, Bijou R, LeJemtel TH. Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure. Circulation. 1994;90:12-16.
55. Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol. 1996;27:1201-1206.
56. Ferrari R, Bachetti T, Confortini R, Opasich C, Febo O, Corti A, Cassani G, Visioli O. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation. 1995;92:1479-1486.
57. Vaddi K, Nicolini FA, Mehta P, Mehta JL. Increased secretion of tumor necrosis factor-alpha and interferon-gamma by mononuclear leukocytes in patients with ischemic heart disease. Circulation. 1994;90:694-699.
58. Maury CPJ, Teppo AM. Circulating tumour necrosis factor-alpha (cachectin) in myocardial infarction. J Intern Med. 1989;225:333-336.
59. Latini R, Bianchi M, Correale E, Dinarello CA, Fantuzzi G, Fresco C, Maggioni AP, Mengozzi M, Romano S, Shapiro L, Sironi M, Tognoni G, Turato R, Ghezzi P. Cytokines in acute myocardial infarction: selective increase in circulating tumor necrosis factor, its soluble receptor, and interleukin-1 receptor antagonist. J Cardiovasc Pharmacol. 1994;23:1-6.
60. Herskowitz A, Chui S, Ansari AA, Wesselingh S. Cytokines mRNA expression in postischemic/reperfused myocardium. Am J Pathol. 1995;146:419-428.
61. Chollet-Martin S, Depoix JP, Hvass U, Pansard Y, Vissuzaine C, Gougerot-Pocidalo MA. Raised plasma levels of tumor necrosis factor in heart allograft rejection. Transplant Proc. 1990;22:283-286.
62. Casey WF, Hauser GJ, Hannallah RS, Midgley FM, Kahn WN. Circulating endotoxin and tumor necrosis factor during pediatric cardiac surgery. Crit Care Med. 1992;20:1090-1096.
63. Hennein HA, Ebba H, Rodriguez JL, Merrick SH, Keith FM, Bronstein MH, Leung JM, Mangano DT, Greenfield LJ, Rankin JS. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg. 1994;108:626-635.
64. Hauler BG, Zeevl A, Oddis CV, Finkel MS. Cytokine induction during cardiac surgery: analysis of TNF-alpha expression pre- and postcardiopulmonary bypass. J Card Surg. 1995;10:418-422.
65. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, DiLoreto C, Beltrami CA, Krajewski S, Reed JC, Anversa P. Apoptosis in the failing human heart. N Engl J Med. 1997;336:1131-1141.
66. Kubota T, McTierman CF, Frye CS, Demetris AJ, Feldman AM. Cardiac-specific overexpression of tumor necrosis factor-alpha causes lethal myocarditis in transgenic mice. J Am Coll Cardiol. 1997;221(suppl A):346A. Abstract.
67. Geller DA, Lowenstein CJ, Shapiro RA, Nussler AK, Di Silvio M, Wang SC, Nakayama DK, Simmons RL, Snyder SH, Billiar TR. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci U S A. 1993;90:3491-3495.
68. Schmid EF, Binder K, Grell M, Scheurich P, Pfizenmaier K. Both tumor necrosis factor receptors, TNFR60 and TNFR80, are involved in signaling endothelial tissue factor expression by juxtacrine tumor necrosis factor alpha. Blood. 1995;86:1836-1841.
69. Bierhaus A, Zhang Y, Deng Y, Mackman N, Quehenberger P, Haase M, Luther T, Muller M, Bohrer H, Greten J. Mechanism of tumor necrosis factor alpha-mediated induction of endothelial tissue factor. J Biol Chem. 1995;270:26419-26432.